S. Monga, L. Valkovič, S. Myerson, S. Neubauer, M. Mahmod, O. Rider
{"title":"非诺贝特作为代谢调节剂增强中重度主动脉瓣狭窄患者心脏生理的一项随机双盲安慰剂对照研究","authors":"S. Monga, L. Valkovič, S. Myerson, S. Neubauer, M. Mahmod, O. Rider","doi":"10.1136/heartjnl-2022-bsci.2","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":117644,"journal":{"name":"Scientific oral presentations","volume":"32 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"OP2 A randomised double-blind placebo-controlled study of fenofibrate as a metabolic modulator to augment cardiac physiology in moderate-severe aortic stenosis\",\"authors\":\"S. Monga, L. Valkovič, S. Myerson, S. Neubauer, M. Mahmod, O. Rider\",\"doi\":\"10.1136/heartjnl-2022-bsci.2\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":117644,\"journal\":{\"name\":\"Scientific oral presentations\",\"volume\":\"32 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Scientific oral presentations\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/heartjnl-2022-bsci.2\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Scientific oral presentations","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/heartjnl-2022-bsci.2","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
OP2 A randomised double-blind placebo-controlled study of fenofibrate as a metabolic modulator to augment cardiac physiology in moderate-severe aortic stenosis